Neurovascular Devices Market to Hit USD 6.30 billion by 2035 | CAGR 24.10%

Read more about this report- Neurovascular Devices Market to Hit USD 6.30 billion by 2035 | CAGR 24.10%

The Neurovascular Devices Market is valued at USD 3.20 billion in 2024 and is projected to reach USD 6.30 billion by 2035, growing at a CAGR of 6.35% from 2025 to 2035.

A major growth driver is the increasing global incidence of stroke and aneurysms, which is creating strong demand for advanced intervention tools. However, a key restraint remains the high cost of neuro-interventional procedures and limited access in low-income regions. An emerging opportunity lies in the integration of AI-assisted imaging and robotic catheter navigation that enhances precision and reduces procedural risks.

The market is segmented by Product Type (Embolization Devices, Stents, Balloons, Clot Retrievers, Guidewires), by Application (Ischemic Stroke, Haemorrhagic Stroke, Cerebral Aneurysm, Arteriovenous Malformations), by Technology (Coiling, Clipping, Flow Diversion, Aspiration), and by End User (Hospitals, Ambulatory Surgical Centres, Specialty Clinics, Academic Institutes). Among these, the Embolization Devices segment is witnessing strong growth due to the rising preference for minimally invasive procedures and the increasing adoption of flow-diverter stents in aneurysm management.

Key application areas include ischemic stroke treatment, aneurysm repair, clot retrieval, haemorrhagic stroke management, and cerebral revascularization. Ischemic stroke treatment is gaining traction with the introduction of next-generation thrombectomy devices and AI-powered imaging platforms that improve diagnosis-to-treatment timelines and patient outcomes.

Accessibility is being driven by healthcare digitization initiatives, public-private partnerships, and stroke awareness programs. In the U.S., for instance, the expansion of certified stroke centres and Medicare coverage for neuro-interventions is accelerating the adoption of neurovascular devices.

The five major regions contributing to this market include North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In China, rising healthcare investments, fast-track regulatory approvals for innovative devices, and the expansion of endovascular treatment centres are fuelling robust market demand.

Prominent companies influencing this space include Medtronic plc, Stryker Corporation, Penumbra Inc., Johnson & Johnson MedTech, and MicroVention Inc. These players are shaping the market through product launches focused on soft-tipped catheters and bioactive coils, strategic acquisitions to expand their neurology portfolios, and partnerships with digital imaging platforms to enable real-time procedural guidance.